Lundbeck silent on shutdown of Indian operations
Despite a complete withdrawal from the market of one of the world's most populous nations, the Danish pharmaceutical giant doesn't want to comment on the reason why, or whether any other domestic operations are facing closedowns.
BY ULRICH QUISTGAARD, TRANSLATED BY DANIEL PEDERSEN
With over 1.3 billion people, India should, on the face of it, appear an attractive drug market for life science firms. Nonetheless, Lundbeck has decided to cease its operations in the Central Asian country completely.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
